These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 7628694

  • 1. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T.
    Genes Dev; 1995 Jul 01; 9(13):1586-97. PubMed ID: 7628694
    [Abstract] [Full Text] [Related]

  • 2. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y.
    Proc Natl Acad Sci U S A; 1995 Nov 07; 92(23):10599-603. PubMed ID: 7479848
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
    Roff M, Thompson J, Rodriguez MS, Jacque JM, Baleux F, Arenzana-Seisdedos F, Hay RT.
    J Biol Chem; 1996 Mar 29; 271(13):7844-50. PubMed ID: 8631829
    [Abstract] [Full Text] [Related]

  • 5. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites.
    Sun SC, Maggirwar SB, Harhaj E.
    J Biol Chem; 1995 Aug 04; 270(31):18347-51. PubMed ID: 7629157
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
    Li CC, Dai RM, Longo DL.
    Biochem Biophys Res Commun; 1995 Oct 04; 215(1):292-301. PubMed ID: 7575604
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
    Gao Y, Lecker S, Post MJ, Hietaranta AJ, Li J, Volk R, Li M, Sato K, Saluja AK, Steer ML, Goldberg AL, Simons M.
    J Clin Invest; 2000 Aug 04; 106(3):439-48. PubMed ID: 10930447
    [Abstract] [Full Text] [Related]

  • 8. A novel in vitro assay for deubiquitination of I kappa B alpha.
    Strayhorn WD, Wadzinski BE.
    Arch Biochem Biophys; 2002 Apr 01; 400(1):76-84. PubMed ID: 11913973
    [Abstract] [Full Text] [Related]

  • 9. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells.
    Traenckner EB, Baeuerle PA.
    J Cell Sci Suppl; 1995 Apr 01; 19():79-84. PubMed ID: 8655651
    [Abstract] [Full Text] [Related]

  • 10. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
    Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW.
    Proc Natl Acad Sci U S A; 1995 Nov 21; 92(24):11259-63. PubMed ID: 7479976
    [Abstract] [Full Text] [Related]

  • 11. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Palombella VJ, Rando OJ, Goldberg AL, Maniatis T.
    Cell; 1994 Sep 09; 78(5):773-85. PubMed ID: 8087845
    [Abstract] [Full Text] [Related]

  • 12. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.
    DiDonato JA, Mercurio F, Karin M.
    Mol Cell Biol; 1995 Mar 09; 15(3):1302-11. PubMed ID: 7862124
    [Abstract] [Full Text] [Related]

  • 13. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
    Krappmann D, Wulczyn FG, Scheidereit C.
    EMBO J; 1996 Dec 02; 15(23):6716-26. PubMed ID: 8978697
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.
    Yaron A, Gonen H, Alkalay I, Hatzubai A, Jung S, Beyth S, Mercurio F, Manning AM, Ciechanover A, Ben-Neriah Y.
    EMBO J; 1997 Nov 03; 16(21):6486-94. PubMed ID: 9351830
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transient nuclear factor kappaB (NF-kappaB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-kappaB linked to chemokine production.
    Uehara T, Matsuno J, Kaneko M, Nishiya T, Fujimuro M, Yokosawa H, Nomura Y.
    J Biol Chem; 1999 May 28; 274(22):15875-82. PubMed ID: 10336492
    [Abstract] [Full Text] [Related]

  • 18. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
    Rodriguez MS, Wright J, Thompson J, Thomas D, Baleux F, Virelizier JL, Hay RT, Arenzana-Seisdedos F.
    Oncogene; 1996 Jun 06; 12(11):2425-35. PubMed ID: 8649784
    [Abstract] [Full Text] [Related]

  • 19. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
    Desterro JM, Rodriguez MS, Hay RT.
    Mol Cell; 1998 Aug 06; 2(2):233-9. PubMed ID: 9734360
    [Abstract] [Full Text] [Related]

  • 20. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
    Mukhopadhyay A, Manna SK, Aggarwal BB.
    J Biol Chem; 2000 Mar 24; 275(12):8549-55. PubMed ID: 10722693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.